Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 31;14(3):e23691.
doi: 10.7759/cureus.23691. eCollection 2022 Mar.

Haematological, Biochemical, and Inflammatory Biomarkers of COVID-19 Patients Hospitalized in Critical Unit: A Retrospective Study

Affiliations

Haematological, Biochemical, and Inflammatory Biomarkers of COVID-19 Patients Hospitalized in Critical Unit: A Retrospective Study

Radi T Alsafi et al. Cureus. .

Abstract

Background: The World Health Organization declared coronavirus disease 2019 (COVID-19) responsible for a catastrophic global pandemic. The complexity of COVID-19 is centred on the unpredictable course of the disease, which can rapidly develop from patients being asymptomatic to having life-threatening symptoms. The unpredictable disease severity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been a major problem facing the healthcare system during the pandemic. Identifying the laboratory biomarkers would help predict SARS-CoV-2 pathogenicity. This study focused on the previous literature regarding three laboratory biomarker profiles: haematological, inflammatory, and biochemical biomarkers.

Methods: A retrospective study of COVID-19 patients was conducted between May 2020 and September 2020 to determine the predictors of hospitalization (severity) in COVID-19 patients. Patients were divided into two groups: those admitted to an intensive care unit (ICU, severe) and those admitted to a non-ICU (stable). Patients' data were obtained from their medical records at Al Noor Specialist Hospital and East Arafat Hospital in Saudi Arabia.

Results: A total of 487 patients with COVID-19, including 304 males and 183 females, were investigated in this study. A total of 217 patients were admitted to the ICU. Patients admitted to the ICU had a higher prevalence of chronic comorbidities than non-ICU patients. D-dimer, white blood cells (WBC), neutrophils, ferritin, C-reactive protein (CRP), lactate dehydrogenase (LDH), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) were more elevated in patients admitted to the ICU compared to non-ICU patients.

Conclusion: Chronic comorbidities are a significant predictor for admission to the ICU. Moreover, tests for D-dimer, WBC, neutrophils, lymphocytes, CRP, LDH, and ALT could be used to predict patients' admission to the ICU.

Keywords: chronic comorbidities; covid-19; icu; inflammatory biomarkers; sars-cov-2.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lu R, Zhao X, Li J, et al. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251.... Lancet. 2020;395:565–574. - PMC - PubMed
    1. A novel coronavirus from patients with pneumonia in China, 2019. Zhu N, Zhang D, Wang W, et al. https://www.nejm.org/doi/full/10.1056/nejmoa2001017. N Engl J Med. 2020;382:727–733. - PMC - PubMed
    1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Chen N, Zhou M, Dong X, et al. https://www.sciencedirect.com/science/article/pii/S0140673620302117. Lancet. 2020;395:507–513. - PMC - PubMed
    1. Analysis of related factors of brittle hip fracture in postmenopausal women with osteoporosis. Zhuang HF, Wang PW, Li YZ, Lin JK, Yao XD, Xu H. https://onlinelibrary.wiley.com/doi/full/10.1111/os.12605. Orthop Surg. 2020;12:194–198. - PMC - PubMed
    1. Laboratory biomarkers of COVID-19 disease severity and outcome: findings from a developing country. Leulseged TW, Hassen IS, Ayele BT, et al. PLoS One. 2021;16:0. - PMC - PubMed

LinkOut - more resources